comparemela.com

Latest Breaking News On - Cornea services - Page 1 : comparemela.com

Yuyu Pharma Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating YP-P10 Ophthalmic Solution for the Treatment of Dry Eye Disease

/PRNewswire/ Yuyu Pharma announces the enrollment of the first patient in a phase 2 clinical study evaluating YP-P10, a novel and patented synthetic peptide.

Soult ukpyolsiSouth koreaUnited statesLauren rosePrnewswire yuyu pharmaYuyu pharmaFrancis mahNoel parkRobert yuCornea services at scripps clinicDrug administrationAmerican academy of ophthalmologyInvestigational new drug applicationCebo efficacyEye care professionalsCornea services

Tarsus Pharmaceuticals, Inc Presents Data from Two Pioneering Studies on the Prevalence and

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesDavid nakasoneBobak azamianExchange commissionAmerican academy of optometry aaoptTarsus pharmaceuticals incDrug administrationKentucky college of optometryAmerican academyChief executive officerPaul karpeckiCornea servicesKentucky eye instituteAssociate professorKentucky collegeTarsus pharmaceuticals

Oyster Point Pharma Announces FDA Approval of TYRVAYA™ (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease

/PRNewswire/ Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced that the U.S. Food and Drug Administration (FDA) has approved TYRVAYA™ (varenicline.

University of cincinnatiUnited statesTed hollandOyster point pharma incOyster point pharma the companyCora incCornea services at cincinnati eye instituteDrug administrationExchange commissionOyster point pharmaNasal sprayPoint pharmaMultichannel newsOyster pointCornea servicesCincinnati eye institute

Ocuphire to Host Key Opinion Leader Event on Nyxol® as a Potential New Treatment Option for Reversing Pharmacologically Induced Mydriasis

Highlights of Recent Positive Data from Nyxol's Phase 3 Registration Trial Roundtable Discussion by 3 KOLs with Unique Perspectives and Distinct Patient .

United statesSusan bentonMina soochPeterk kaiserPeter kaiserPaulm karpeckiCorey davisOcuphire pharmaJay peposeSciences at washington university school of medicineSchool of medicinePennsylvania college of optometryNational institute of healthBrandeis universityGeorgetown university medical centerGaddie eye centers in louisville

vimarsana © 2020. All Rights Reserved.